1 BTC
=
- USD
Sanmina Corp
As of May 31, 2026 at 24:02 UTC
Chart
About Sanmina Corp
Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense, and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue mainly in the United States, China, and Mexico, but has a presence around the world.
Market Statistics
Trading Metrics
How to Buy SANM
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy SANM
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesAMD disclosed a $6.5 million stake in Marvell Technology through its latest 13F filing, with the position showing an estimated unrealized gain of approximately $4.3 million as Marvell shares have risen about 66% from AMD's implied entry price. The investment reflects AMD's exposure to AI infrastructure and data center semiconductor opportunities. AMD also holds positions in Absci Corp, Sanmina Corp, and Xanadu Quantum Technologies.
The global medical device contract development and manufacturing organization (CDMO) market is expected to expand significantly at a CAGR of 13.12% from 2026 to 2033, driven by increased outsourcing by OEMs, demand for advanced connected devices, and the shift toward home care and minimally invasive treatments. CDMOs are becoming essential partners for managing regulatory complexities, reducing capital expenditure, and accelerating time-to-market.
Sanmina's stock dropped nearly 22% despite beating earnings estimates on both revenue ($3.19B vs $3.09B expected) and net income ($2.38 per share vs $2.14 expected). The sharp decline was driven by disappointing forward guidance, with the company projecting Q2 net sales of $3.1-$3.4 billion, falling short of analyst expectations of $3.52 billion. The market's high expectations for AI-related growth companies left no room for guidance misses.
Sanmina plans a new factory in Texas targeting the U.S. energy market and partnered with a Croatian company to co-design transformers, but investors are concerned about potential cash burn and high valuation.
The global In-Vitro Diagnostic (IVD) contract manufacturing market is projected to grow from USD 21.13 billion in 2024 to USD 56.9 billion by 2034, driven by increasing demand for advanced diagnostic tests and rising chronic disease prevalence.